Volume 2, Emitir 9 (2012)
Revisão: Resultados da Trilha Clínica
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Revisão: Resultados da Trilha Clínica
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Revisão: Resultados da Trilha Clínica
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Atualização de pesquisa
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Revisão: Resultados da Trilha Clínica
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Revisão: Resultados da Trilha Clínica
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Revisão: Resultados da Trilha Clínica
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
